Skip to main content

Table 3 Factors influencing the plasma bepridil concentration ≥800 ng/mL in patients with HF on multivariate logistic analysis

From: Effect of polypharmacy on plasma bepridil concentration in patients with heart failure: a multicenter retrospective study

Factors

Adjusted OR

95% CI

p value

Age ≥70 years

1.90

0.571–6.321

0.295

Daily dose of bepridil ≥1.6 mg/kg body weight

6.82

2.104–22.132

0.001

Polypharmacy

2.96

1.014–8.643

0.047

Concomitant of aprindine

8.63

1.684–44.215

0.010

Ccr ≤30 mL/min

2.75

0.848–8.927

0.092

LVEF ≤50%

1.76

0.578–5.358

0.320

  1. Ccr Creatinine clearance, LVEF Left ventricular ejection fraction, OR Odds ratio, 95% CI 95% coefficient interval